The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I trial of in situ vaccination with autologous CCL21-modified dendritic cells (CCL21-DC) combined with pembrolizumab for advanced NSCLC.
 
Aaron E. Lisberg
Employment - Boston Scientific (I)
Stock and Other Ownership Interests - Boston Scientific (I)
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Jazz Pharmaceuticals; Leica Biosystems; Lilly; MorphoSys; Novartis; Novocure; Oncocyte; Pfizer; Sanofi/Regeneron
Research Funding - AstraZeneca; Calithera Biosciences; Daiichi Sankyo; Dracen; WindMIL
 
Bin Liu
No Relationships to Disclose
 
Ramin Salehi-Rad
No Relationships to Disclose
 
Jay M. Lee
Stock and Other Ownership Interests - Moderna Therapeutics
Consulting or Advisory Role - AstraZeneca; Bristol Myers Squibb Foundation; Genentech/Roche; Novartis
Travel, Accommodations, Expenses - Genentech/Roche; Genentech/Roche
(OPTIONAL) Uncompensated Relationships - Genentech/Roche; Novartis
 
Linh Tran
No Relationships to Disclose
 
Kostyantyn Krysan
No Relationships to Disclose
 
Raymond Lim
No Relationships to Disclose
 
Camelia Dumitras
No Relationships to Disclose
 
Zhe Jiang
No Relationships to Disclose
 
Fereidoun Abtin
No Relationships to Disclose
 
Robert Suh
No Relationships to Disclose
 
Scott Genshaft
No Relationships to Disclose
 
Scott Oh
Speakers' Bureau - Intuitive Surgical
Travel, Accommodations, Expenses - Intuitive Surgical
 
Gregory A Fishbein
No Relationships to Disclose
 
Ciara M O'Higgins
No Relationships to Disclose
 
Shay Ashouri
No Relationships to Disclose
 
Jonathan W. Goldman
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Lilly; Pfizer
Research Funding - Abbvie (Inst); Advaxis (Inst); Array BioPharma (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Genentech/Roche (Inst); Lilly (Inst); Pfizer (Inst); Spectrum Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
David Elashoff
No Relationships to Disclose
 
Edward B. Garon
Consulting or Advisory Role - ABL Bio; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Gilead Sciences; GlaxoSmithKline; Lilly; Merck; Natera; Novartis; Personalis; Sanofi/Regeneron; Shionogi; Xilio Therapeutics
Research Funding - ABL Bio (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Dynavax Technologies (Inst); EMD Serono (Inst); Genentech (Inst); Iovance Biotherapeutics (Inst); Lilly (Inst); Merck (Inst); Mirati Therapeutics (Inst); Neon Therapeutics (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Diagnosistic and therapeutic use of "Motif Neoepitopes" as defined by Cummings et al in Nature Cancer. (Inst)
 
Steven M. Dubinett
Stock and Other Ownership Interests - EarlyDiagnostics; LungLife AI
Consulting or Advisory Role - EarlyDiagnostics; LungLife AI; T-Cure Bioscience
Research Funding - Janssen Research & Development